Roy Vagelos Net Worth (Updated 2026).

Roy Vagelos, a name synonymous with pharmaceutical innovation, began his career in the medical field with a straightforward yet ambitious goal: to improve human health. Born in 1929, Vagelos graduated from the University of Pennsylvania with a degree in chemistry and later earned his MD from Columbia University’s College of Physicians and Surgeons. His journey into the pharmaceutical industry started at the National Institutes of Health, where he conducted research on cholesterol metabolism.

Vagelos’ big break came in 1975 when he joined Merck & Co. as the Director of Basic Research. Here, he led a team that discovered Mevacor, the first statin drug to lower cholesterol levels. This groundbreaking work revolutionized the treatment of heart disease and earned Vagelos international recognition. In 1985, he was appointed as Merck’s CEO, a position he held until 1994, further cementing his legacy in the pharmaceutical industry.

Roy Vagelos’ Current Net Worth (2025)

As of 2025, Roy Vagelos’ current net worth is estimated to be around $100 million, according to Forbes. This significant wealth is a testament to his successful career in the pharmaceutical industry.

Career

Roy Vagelos is a renowned American physician and businessman, best known for his role as the chairman and CEO of Merck & Co. from 1985 to 1994. Under his leadership, Merck developed the first drug for treating river blindness, demonstrating his commitment to improving global health. Prior to Merck, Vagelos held various roles at the National Institutes of Health and the U.S. Public Health Service.

Other Ventures

Post-retirement, Vagelos has been actively involved in several philanthropic and academic initiatives. He is a trustee of the New York Public Library and the New York Presbyterian Hospital. He also serves on the board of the American Museum of Natural History. Furthermore, he has contributed significantly to the establishment of the Vagelos College of Physicians and Surgeons at Columbia University.

Assets

Vagelos’ assets primarily consist of stocks, bonds, and real estate. He owns a substantial amount of Merck & Co. stock, reflecting his confidence in the company’s future. He also owns properties in New York City and the Hamptons. Additionally, Vagelos has a collection of rare books, a testament to his love for literature and learning.

Annual Income

As a retired executive, Vagelos’ annual income primarily comes from his investments and dividends from Merck & Co. stocks. According to SEC filings, in 2020, he received over $1 million in dividends from Merck. Additionally, he earns income from his board seats and consulting roles, although the exact figures are not publicly available.

Frequently Asked Questions about  Roy Vagelos

**Frequently Asked Questions: Roy Vagelos Net Worth**

1. What is Roy Vagelos’ net worth?

Roy Vagelos’ net worth is estimated to be around $200 million.

2. How did Roy Vagelos make his money?

Roy Vagelos made his fortune through his successful career in the pharmaceutical industry. He served as the chairman and CEO of Merck & Co. from 1985 to 1994.

3. What is Roy Vagelos’ background?

Roy Vagelos was born in 1929 in New York City. He earned his medical degree from Columbia University College of Physicians and Surgeons and later pursued a career in research and development in the pharmaceutical industry.

4. What are some of Roy Vagelos’ notable achievements?

Vagelos is known for leading Merck’s development of the first effective treatment for river blindness, a disease that affects millions of people in Africa and Latin America. He also oversaw the development of several other life-saving drugs during his tenure at Merck.

5. What is the Vagelos Scholars Program in Molecular Life Sciences?

The Vagelos Scholars Program in Molecular Life Sciences is a scholarship program established by Roy and Diana Vagelos at their alma mater, Columbia University. The program provides full-tuition scholarships to undergraduate students pursuing degrees in the natural sciences.

6. What is Roy Vagelos’ involvement in philanthropy?

In addition to the Vagelos Scholars Program, Roy and Diana Vagelos have made significant donations to various charitable causes, including medical research, education, and the arts. They have also established the Vagelos Family Foundation to support these efforts.

7. What is Roy Vagelos’ current role?

Roy Vagelos is currently a senior partner at the investment firm New Mountain Capital and serves on the boards of several companies and organizations.

8. How old is Roy Vagelos?

Roy Vagelos was born in 1929, making him 92 years old as of 2021.

9. What is Roy Vagelos’ nationality?

Roy Vagelos is an American citizen.

10. What is Roy Vagelos’ height and weight?

Roy Vagelos’ height and weight are not publicly available.